Attached files
| file | filename |
|---|---|
| EX-31.1 - EXHIBIT 31.1 - Myovant Sciences Ltd. | myovantex311.htm |
| EX-32.2 - EXHIBIT 32.2 - Myovant Sciences Ltd. | myovantex322.htm |
| EX-32.1 - EXHIBIT 32.1 - Myovant Sciences Ltd. | myovantex321.htm |
| EX-31.2 - EXHIBIT 31.2 - Myovant Sciences Ltd. | myovantex312.htm |
| EX-21.1 - EXHIBIT 21.1 - Myovant Sciences Ltd. | myovantex211.htm |
| EX-10.26 - EXHIBIT 10.26 - Myovant Sciences Ltd. | myovantex1026.htm |
| 10-K - 10-K - Myovant Sciences Ltd. | myovant10kmarch312018.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following Registration Statements of Myovant Sciences Ltd.:
(1) | Registration Statement (Form S-8 No. 333-218057) pertaining to the 2016 Equity Incentive Plan, and |
(2) | Registration Statement (Form S-3 No. 333-221526); |
of our report dated June 7, 2018, with respect to the consolidated financial statements of Myovant Sciences Ltd. included in this Annual Report (Form 10-K) of Myovant Sciences Ltd. for the year ended March 31, 2018.
/s/ Ernst & Young LLP
Iselin, New Jersey
June 7, 2018